Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Product categories
Product categories
Personal Care (Topical)
Products 11 to 20 of 20
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Mandelic Acid
by
MONAD Nanotech
+
Birla College
Biotech components:
Plant
Business models:
B2B
Country of production:
India
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
University
+
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Personal Care (Topical)
+
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Muck Daddy (TM)
by
Amyris
Biotech components:
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
Commercial
+
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:47 (6 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Neossance Hemisqualane
by
Aprinnova
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Japan
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Neossance Squalane
by
Aprinnova
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
Australia
+
Canada
+
China
+
Europe
+
Japan
+
Korea
+
Mexico
+
New Zealand
+
Philippines
+
Russia
+
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Resveratrol
by
Evolva
Biotech components:
Microbe
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
+
Personal Care (Topical)
+
Personal Care (Ingested)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
Squalane
by
Nucelis
Biotech components:
Animal
+
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:30 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Succinic Acid
by
Myriant
+
Royal DSM
+
BioAmber, Inc.
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:37 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Health
+
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
+
Chemical
+
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
Yarrowia Oils
by
Nucelis
Biotech components:
Plant
Business models:
N/A
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Health
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
Production process:
Open Release
Source:
N/A
Trading symbol:
N/A
Value chain stage:
Finished Product
Zemea® 1,3-Propanediol
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
+
UK
Country of distribution:
USA
+
Asia Pacific
+
Europe
Intended consumer:
Consumer
+
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Zemea USP
by
DuPont
+
Tate & Lyle Bio Products
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
+
UK
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/19 16:00 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Health
+
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
+
Chemical
+
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
1
2
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
